Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Varex Imaging (VREX) Research & Development (2016 - 2026)

Varex Imaging (VREX) has disclosed Research & Development for 11 consecutive years, with $21.7 million as the latest value for Q1 2026.

  • Quarterly Research & Development fell 7.66% to $21.7 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $89.3 million through Jan 2026, down 0.78% year-over-year, with the annual reading at $91.1 million for FY2025, 4.71% up from the prior year.
  • Research & Development for Q1 2026 was $21.7 million at Varex Imaging, down from $24.2 million in the prior quarter.
  • The five-year high for Research & Development was $24.2 million in Q4 2025, with the low at $18.9 million in Q2 2022.
  • Average Research & Development over 5 years is $21.5 million, with a median of $21.8 million recorded in 2023.
  • The sharpest move saw Research & Development grew 21.69% in 2023, then dropped 7.66% in 2026.
  • Over 5 years, Research & Development stood at $20.0 million in 2022, then rose by 2.5% to $20.5 million in 2023, then increased by 6.83% to $21.9 million in 2024, then grew by 10.5% to $24.2 million in 2025, then fell by 10.33% to $21.7 million in 2026.
  • According to Business Quant data, Research & Development over the past three periods came in at $21.7 million, $24.2 million, and $21.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.